Dossier
rare disease treatments
Coverage of rare disease treatments in the Nexus archive.
- STAT+: Pharmalittle: We’re reading about a Lilly threat to 340B hospitals, Ebola vaccine funding, and more
Eli Lilly is threatening to cut off price discounts from 340B hospitals that fail to submit required claims data, aiming to prevent duplicate discounts. The FDA is set to hold a closed-door meeting with rare disease advocates to discuss regulatory challenges for drug approvals.